Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gliomas molecular markers: importance in treatment, prognosis and applicability in brazilian health system.

Anais da Academia Brasileira de Ciencias - 1 Jan 2022

Soldatelli Jéssica S, Oliveira Iuri M DE, Kneubil Maximiliano C, Henriques João Antonio P

Abstract excerpt

Gliomas represent 80% of all primary malignant brain tumors in adults. In view of this public health problem, the early detection through sensitive and specific molecular tumor markers analysis can help to improve gliomas diagnosis and prognosis as well as their staging, assessment of therapeutic response and detection of recurrence. Therefore, this review focuses in current gliomas tumor markers, IDH-1/2,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brazil

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to Prognosis

Source

Identifiers

PMID: 35766600
DOI: 10.1590/0001-3765202220211075

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gliomas molecular markers: importance in treatment, prognosis and applicability in brazilian health system.PMID 35766600Read ↗

Study of Molecular Markers in Glioma and Their Association with Clinicopathological Features.Semantic proximity Read ↗

[Advances of glioma biomarkers].Semantic proximity Read ↗

[Advance of molecular subtyping and precise treatment for gliomas].Semantic proximity Read ↗

[How molecular biology can improve the clinical diagnosis of gliomas?]Semantic proximity Read ↗

Updates in prognostic markers for gliomasSemantic proximity Read ↗

A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnosticsSemantic proximity Read ↗

Prognostic and Predictive Biomarkers in Gliomas.Semantic proximity Read ↗

New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M.Semantic proximity Read ↗

Incidence of biomarkers in high-grade gliomas and their impact on survival in a diverse SouthEast Asian cohort - a population-based study.Semantic proximity Read ↗

Early Detection of Glioma: Investigating Inflammatory Markers (CRP), Kidney, and Liver Function.Semantic proximity Read ↗

Role of Molecular Pathology in the Treatment of Anaplastic Gliomas and Glioblastomas.Semantic proximity Read ↗

Adult Glioma WHO Classification Update, Genomics, and ImagingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.